Nephros, Inc. (NEPH)
Nasdaq: NEPH · Surgical & Medical Instruments & Apparatus · South Orange, NJ · filing with the SEC since 2002
Grade6.2
◀ Past 4.9● Present 6.8▶ Future 6.5
Filings
304 filings since 2017 beside 149 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by May 15, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Oct 14, 2026.
Filings a yearinsider forms included
7949523034262625
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Apr 28, 2025.SEC letters: 2 in the last 36 months, the newest May 21, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 26, 2025
8-K items 1.01, 1.02
Major agreement signed; Major agreement ended · Current report
Nov 21, 2025
May 24, 2024
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 23, 2024
40 of 304 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.